1. An Ion‐Enhanced Oncolytic Virus‐Like Nanoparticle for Tumor Immunotherapy.
- Author
-
Wu, Fan, Li, Yanli, Meng, Yun, Cai, Xuechao, Shi, Jieyun, Li, Jinjin, Chen, Yang, Zhang, Li, Meng, Xianfu, Li, Huiyan, Jiang, Xingwu, Fu, Zhenxiao, Wu, Yelin, and Bu, Wenbo
- Subjects
- *
T cells , *IMMUNOTHERAPY , *TUMOR microenvironment , *TUMOR treatment , *TUMORS - Abstract
T lymphocytes (T cells) are essential for tumor immunotherapy. However, the insufficient number of activated T cells greatly limits the efficacy of tumor immunotherapy. Herein, we proposed an oncolytic virus‐mimicking strategy to enhance T cell recruitment and activation for tumor treatment. We constructed an oncolytic virus‐like nanoplatform (PolyIC@ZIF‐8) that was degraded in the acidic tumor environment to release PolyIC and Zn2+. The released PolyIC exhibited an oncolytic virus‐like function that induced tumor cell apoptosis and promoted T cell recruitment and activation through a tumor antigen‐dependent manner. More importantly, the released Zn2+ not only enhanced T cell recruitment by inducing CXCL9/10/11 expression but also promoted T cell activation to increase interferon‐γ (INF‐γ) expression by inducing the phosphorylation of ZAP‐70 via a tumor antigen‐independent manner. This Zn2+‐enhanced oncolytic virus‐mimicking strategy provides a new approach for tumor immunotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF